日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

转移性乳腺癌患者中TOP1突变和抗体药物偶联物的交叉耐药性

Abelman Rachel O, Wu Bogang, Barnes Haley, Medford Arielle, Norden Bryanna, Putur Annika, Bitman Elena, Thant Win, Liu Ting, Weipert Caroline, Fell Geoffrey, Spring Laura M, Wander Seth A, Moy Beverly, Vidula Neelima, Isakoff Steven J, Varkaris Andreas, Juric Dejan, Corcoran Ryan B, Ellisen Leif W, Bardia Aditya

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer

转移性乳腺癌中ctDNA谱、靶向治疗使用和预后的种族差异

Podany, Emily L; Foffano, Lorenzo; Gerratana, Lorenzo; Medford, Arielle J; Clifton, Katherine; Tapiavala, Shaili; Velimirovic, Marko; Lipsyc-Sharf, Marla; Reduzzi, Carolina; Bubie, Adrian; Putur, Annika; Ademuyiwa, Foluso O; Puglisi, Fabio; Gradishar, William J; Ma, Cynthia X; Bardia, Aditya; Cristofanilli, Massimo; Davis, Andrew A